A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes

Status:
Completed

Trial end date:
2006-02-01

Target enrollment:

Participant gender:

This study was designed to directly assess the effects of vildagliptin on gastric emptying in people with type 2 diabetes.

Phase 3

Novartis Pharmaceuticals

Vildagliptin